2021 annual financial data
Zevra Therapeutics 2021 Net margin
Zevra Therapeutics 2021 net margin with verified reported values.
Direct answer
Net margin was -29.86%.
Operating income was 7,729,000 USD and net income was -8,555,000 USD.
Operating cash flow was 10,439,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,650,000 USD
- Operating income
- 7,729,000 USD
- Net income
- -8,555,000 USD
- Operating cash flow
- 10,439,000 USD